Pharmaron Beijing Co., Ltd. is a leading pharmaceutical research and development company based in China. With a low-risk ESG score of 14.5, the company specializes in providing a wide range of services to support the life science industry, including drug research and development in various fields such as synthetic, medicinal, and analytical chemistry. Pharmaron offers services in biology, DMPK, pharmacology, drug safety assessment, radiochemistry, isotopically labelled metabolism, chemical and pharmaceutical development, as well as clinical development. The company's operations are divided into segments such as Laboratory services, CMC (small molecule CDMO) services, Clinical development services, and biologics and CGT services, with Laboratory services being the top revenue-generating segment.